Akebia raises $14 million

Akebia Therapeutics Inc. (Cincinnati, Ohio) raised $14 million in the first close of a planned $22 million series B round led by existing investors Novartis Venture Fund and Venture Investors. Existing investors Triathlon Medical Ventures; Kearny Venture Partners; Athenian Venture Partners; and Sigvion Capital and new investor AgeChem Venture Fund participated. ...